- Approval Id
- 1b8ec80e5125eef4
- Drug Name
- ALPHAGAN OPHTHALMIC SOLUTION 0.2%
- Product Name
- ALPHAGAN OPHTHALMIC SOLUTION 0.2%
- Approval Number
- SIN09788P
- Approval Date
- 1998-05-27
- Registrant
- ABBVIE PTE. LTD.
- Licence Holder
- ABBVIE PTE. LTD.
- Drug Type
- Therapeutic
- Forensic Classification
- PRESCRIPTION ONLY MEDICINES
- Dosage Form
- SOLUTION
- Dosage
- <p><strong>DOSAGE AND ADMINISTRATION</strong><br>
The recommended dose is one drop of ALPHAGAN® in the affected eye(s) two times daily. For those patients whose IOP peaks in the afternoon or need additional IOP control, an additional drop of brimonidine in the afternoon can be added.</p>
<p>If more than one topical ophthalmic drug is to be used, the different drugs should be instilled at least 5 minutes apart.</p>
- Route Of Administration
- OPHTHALMIC
- Indication Info
- <p><strong>INDICATIONS AND USAGE</strong><br>
ALPHAGAN® is indicated for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The IOP lowering efficacy of ALPHAGAN® ophthalmic solution diminishes over time in some patients. This loss of effect appears with a variable time of onset in each patient and should be closely monitored.</p>
- Contraindications
- <p><strong>CONTRAINDICATIONS</strong><br>
ALPHAGAN® is contraindicated in patients with hypersensitivity to brimonidine tartrate or any component of this medication. It is also contraindicated in patients receiving monoamine oxidase (MAO) inhibitor therapy and contraindicated in neonates and infants (children under the age of 2 years).</p>
- Atc Code
- S01EA05
- Atc Item Name
- brimonidine
- Pharma Manufacturer Name
- ABBVIE PTE. LTD.
- Company Detail Path
- /organization/abbvie-pte-ltd
